4.7 Article

Quantitative MRI measures of cartilage predict knee replacement: a case-control study from the Osteoarthritis Initiative

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 72, 期 5, 页码 707-714

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2011-201164

关键词

-

资金

  1. OAI [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]
  2. National Institutes of Health, a branch of the Department of Health and Human Services
  3. Merck Research Laboratories
  4. Novartis Pharmaceuticals Corporation
  5. GlaxoSmithKline
  6. Pfizer, Inc.
  7. Novartis Pharma AG (Basel, Switzerland)
  8. University of Pittsburgh (Pivotal OAI MRI Analyses POMA: NIH/NHLBI) [HHSN2682010000 21C]
  9. OAI coordinating centre at University of California, San Francisco [N01-AR-2-2258]
  10. University of Pittsburgh Multidisciplinary Clinical Research Center (MCRC) for Rheumatic and Musculoskeletal Diseases [P60 AR054731]
  11. Pfizer
  12. Eli Lilly
  13. MerckSerono
  14. Glaxo Smith Kline
  15. Centocor RD
  16. Wyeth
  17. Novartis
  18. Stryker
  19. Astra-Zeneca

向作者/读者索取更多资源

Objective Knee osteoarthritis commonly requires joint replacement, substantially reduces quality of life and increases healthcare utilisation and costs. This study aimed to identify whether quantitative measures of articular cartilage structure predict knee replacement, and to establish their utility as outcomes in clinical trials of disease-modifying therapy. Methods A nested case-control study was performed in Osteoarthritis Initiative participants, a multicentre observational cohort of 4796 participants with or at risk of knee osteoarthritis. 127 knees were replaced between baseline and 4 years follow-up, and one control knee per case matched for baseline radiographic disease stage (Kellgren-Lawrence grade; KLG), gender and age. Quantitative cartilage measures were obtained from 3 T magnetic resonance images at the exam before knee replacement, and longitudinal change during the previous 12 months when available (n=110). Results Cartilage thickness loss in the central and total medial femorotibial compartment (primary and secondary predictor variables) was significantly greater in case than control knees (AUC=0.59/0.58). Differences in cartilage loss were greater at earlier than later radiographic disease stages (p<0.01 for interaction with KLG). Cartilage thickness loss in the central tibia was the most predictive longitudinal measure (AUC=0.64). Denuded bone areas in the medial femur were the most predictive and discriminatory cross-sectional measure between case and control knees (AUC=0.66). Conclusions This study demonstrates the predictive value of quantitative, MRI-based measures of cartilage for the clinically relevant endpoint of knee replacement, providing support for their utility in clinical trials to evaluate the effectiveness of structure-modifying intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据